We envision that TF-oriented research on enhancers and SEs should be broadly conducted on model systems and clinical specimens, by utilizing cutting-edge sequencing-based technologies, in order for such complex phenomena of cancer pathogenesis to become entirely resolved. Here, TF is linked to cancer.